![]() |
市场调查报告书
商品编码
1954619
磨牙症治疗市场规模、占有率、成长及全球产业分析:依类型、应用和地区划分的洞察与预测(2026-2034 年)Sleeping Bruxism Treatment Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025 年全球磨牙症治疗市场规模为 4.4801 亿美元,预计 2026 年将成长至 4.7735 亿美元,到 2034 年将达到 8.258 亿美元。这意味着在预测期内,复合年增长率 (CAGR) 为 7.09%。北美地区在 2025 年将占市场领先地位,市场占有率达 36.08%(相当于 1.6165 亿美元),这主要得益于成人磨牙症的高发生率、广泛的认知以及完善的牙科专业人员网络。
睡眠磨牙症是一种睡眠期间不自主地咬紧或磨牙的疾病,可导致头痛、下颚疼痛和牙齿磨损。焦虑、压力、睡眠障碍和阻塞性睡眠呼吸中止症等因素导致磨牙症风险增加,推动了市场成长。医院、诊所和线上药局提供的治疗方案的扩展也促进了市场成长。
市场动态
成长因素
睡眠磨牙症的盛行率在全球范围内不断上升。朱拉隆功大学2023年3月的一项研究表明,约49.7%的阻塞性睡眠呼吸中止症患者同时患有睡眠磨牙症。公众意识的提高、对牙套和牙夹板等非侵入性治疗需求的增长以及诊断技术的进步,正在推动磨牙症治疗方案在全球范围内的普及。
抑制因子
儘管磨牙症盛行率很高,但由于报告不足、认知度低以及缺乏普遍认可的治疗方法,实际治疗率仍然有限。例如,2020 年土耳其的一项研究报告显示,只有 3.8% 的家长为孩子寻求磨牙症治疗,凸显了盛行率与治疗利用率之间的差距,而这正是限制市场成长的因素。
机会
具有生物回馈功能的智慧牙套正在成为重要的成长机会。这些设备可以监测下颚运动,并提供即时回馈,帮助患者减少磨牙的频率。根据克利夫兰诊所2023年10月的报告,Prevent Biometrics公司的智慧牙套能够捕捉下颚运动,并透过无线方式传输数据,从而为预防性治疗提供精准的测量数据。
市场趋势
客製化和3D列印技术的进步正在改变磨牙症的治疗方式。 3D列印技术能够精确地数位化製造牙套,从而提高舒适度、贴合度和耐用性。整合感测器后,智慧牙套可以监测下颚活动并提供即时回馈,因此越来越受到成人、运动员和重度磨牙症患者的青睐。
市场挑战
行为疗法、肉毒桿菌注射和肌肉鬆弛剂等替代治疗方案的日益普及,正在降低人们对基于器械的治疗的需求。新器械的监管壁垒可能会进一步延迟其市场准入,并限制其普及。根据美国国家生物技术资讯中心 (NCBI) 2023 年 7 月的报告,肉毒桿菌注射对常规治疗无效的患者有效,这凸显了其与传统护齿器解决方案的竞争。
依产品类型:市场细分为护齿器、牙套和其他产品。预计到 2026 年,护齿器将占市场主导地位,市占率达 51.79%。 这主要归功于护齿器作为市售产品易于取得、价格实惠以及可客製化设计。例如,Quip 公司于 2023 年 11 月推出了客製化 Quip Night Guard,将其专业级解决方案拓展至消费者市场。
依患者类型:成年人将主导市场,预计到 2026 年将占 76.15% 的市场占有率。这主要是由于颞颚关节障碍 (TMD)、头痛和牙齿裂缝在成年人群中较为常见。儿科细分市场预计将以 6.4% 的复合年增长率成长。
依最终用户划分:牙科诊所在 2025 年占市场主导地位,预计到 2026 年将保持 41.59% 的市场占有率。这是因为大多数客製化设备都由牙医开立处方并进行安装。随着非处方药和智慧型设备的普及,家庭护理领域预计将以 6.8% 的复合年增长率成长。
The global sleeping bruxism treatment market was valued at USD 448.01 million in 2025 and is projected to grow to USD 477.35 million in 2026, reaching USD 825.8 million by 2034, representing a CAGR of 7.09% during the forecast period. North America dominated the market in 2025 with a 36.08% share, equivalent to USD 161.65 million, driven by high adult prevalence rates, widespread awareness, and a dense network of dental professionals.
Sleep bruxism is a disorder characterized by involuntary teeth clenching or grinding during sleep, which can cause headaches, jaw pain, and dental wear. The market growth is driven by rising anxiety, stress, sleep disorders, and obstructive sleep apnea, which increase bruxism risk. The expanding availability of treatment options through hospitals, clinics, and online pharmacies also contributes to market expansion.
Market Dynamics
Drivers
The prevalence of sleep bruxism is increasing globally. Studies, such as one from Chulalongkorn University in March 2023, indicate that approximately 49.7% of adults with obstructive sleep apnea exhibit sleep bruxism. Growing public awareness, rising demand for non-invasive treatments like mouth guards and splints, and improved diagnostic technologies are boosting the adoption of bruxism treatment solutions worldwide.
Restraints
Despite high prevalence, actual treatment adoption remains limited due to underreporting, low awareness, and lack of universally accepted therapeutic options. For example, a 2020 study in Turkey reported that only 3.8% of parents sought treatment for their children's bruxism, highlighting the gap between prevalence and treatment usage, which is restricting market growth.
Opportunities
Smart mouth guards with biofeedback features are emerging as a major growth opportunity. These devices monitor jaw activity, provide real-time feedback, and train patients to reduce grinding episodes. According to the Cleveland Clinic in October 2023, Prevent Biometrics' Intelligent Mouthguard captures jaw movements and transmits data wirelessly, providing precise measurements for preventive therapy.
Market Trends
Advances in custom-fit and 3D printing technologies are transforming bruxism treatment. 3D printing allows for precise digital fabrication of mouth guards, enhancing comfort, fit, and durability. Integration with sensors enables smart mouth guards that monitor jaw activity while offering real-time feedback, increasing adoption among adults, athletes, and patients with severe bruxism.
Market Challenges
Alternative treatment options, including behavioral therapies, Botox injections, and muscle relaxants, are reducing demand for device-based treatments. Regulatory hurdles for new devices can further delay market entry and limit adoption. According to NCBI (July 2023), Botulinum toxin injections are effective for patients unresponsive to conventional therapies, highlighting competition with traditional mouth guard solutions.
By Product Type: The market is divided into mouth guards, splints, and others. The mouth guards segment led in 2026 with a 51.79% share, due to OTC availability, affordability, and custom-fitted designs. For example, in November 2023, Quip launched custom-fit Quip Night Guards, expanding professional-grade solutions to consumers.
By Patient Type: Adults dominate the market, holding 76.15% share in 2026, due to higher prevalence of temporomandibular disorders (TMD), headaches, and cracked teeth. The pediatric segment is projected to grow at a CAGR of 6.4%.
By End-User: Dental clinics dominated in 2025, maintaining 41.59% share in 2026, as most custom devices are prescribed and fitted by dentists. Homecare is projected to grow at a CAGR of 6.8% as OTC and smart devices gain traction.
Competitive Landscape
The market is moderately consolidated with key players including SomnoMed, Procter & Gamble (Plackers), Dentsply Sirona, Smile Brilliant, Ivoclar Vivadent, Henry Schein, Quip, Sunstar Group, and ResMed. Strategic initiatives focus on customized devices, innovative materials, digital fabrication, partnerships with dental providers, and online channel expansion.
Recent Developments:
Conclusion
The global sleeping bruxism treatment market, valued at USD 448.01 million in 2025, is projected to grow to USD 477.35 million in 2026 and USD 825.8 million by 2034, at a CAGR of 7.09%. Market growth is supported by rising prevalence of bruxism, increasing awareness, technological advancements in smart and 3D-printed devices, and expanding dental infrastructure. While limited treatment adoption and alternative therapies pose challenges, innovations in personalized solutions and the growing adult patient population are expected to sustain market expansion through 2034.
Segmentation By Product Type, Patient Type, End-user, and Region
By Product Type * Mouth Guards
By Patient Type * Adults
By End-user * Hospitals
By Region * North America (By Product Type, Patient Type, End-user, and Country)